Filing Flows › Companies › Moderna › Timeline
Moderna stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+944.8% to $254.19
Moderna (MRNA) stock rose 945% over the last 252 sessions, to $254.19. On the way it reported 5 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside) and 8 Form 144 notices of planned sales, and the company filed 5 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 6, 2026 | Earnings | Earnings: beat the EPS estimate by 130.3% | +5.1% (+4.8% vs SPY) | — | — |
| Oct 15, 2026 | Form 144 | Form 144: Stephen Hoge plans to sell $8.6M | +4.4% (+4.1% vs SPY) | +8.3% (+7.8% vs SPY) | — |
| Oct 14, 2026 | Form 144 | Form 144: Stephen Hoge plans to sell $8.4M | +4.5% (+5.6% vs SPY) | +11.3% (+12.4% vs SPY) | — |
| Sep 30, 2026 | 8-K | Directors and officers: departures, appointments, pay | −5.5% (−5.3% vs SPY) | −8.2% (−10.1% vs SPY) | +5.1% (+4.1% vs SPY) |
| Sep 15, 2026 | Form 144 | Form 144: Stephen Hoge plans to sell $5.9M | −2.0% (−1.5% vs SPY) | +16.5% (+14.6% vs SPY) | +38.8% (+36.3% vs SPY) |
| Sep 14, 2026 | Form 144 | Form 144: Stephen Hoge plans to sell $5.8M | +1.9% (+2.3% vs SPY) | +6.8% (+6.9% vs SPY) | +39.5% (+37.5% vs SPY) |
| Sep 10, 2026 | Form 144 | Form 144: James M Mock plans to sell $4.7M | +0.7% (+1.3% vs SPY) | +7.1% (+8.2% vs SPY) | +37.3% (+35.6% vs SPY) |
| Sep 1, 2026 | 8-K | Material definitive agreement | −2.3% (−2.7% vs SPY) | −12.9% (−13.0% vs SPY) | +20.3% (+19.7% vs SPY) |
| Sep 1, 2026 | Form 144 | Form 144: Shannon Klinger plans to sell $486K | +9.5% (+10.1% vs SPY) | 0.0% (+0.1% vs SPY) | +31.6% (+32.0% vs SPY) |
| Aug 5, 2026 | Form 144 | Form 144: Stephane Bancel plans to sell $29.0M | −1.3% (−1.1% vs SPY) | +6.1% (+6.2% vs SPY) | +97.3% (+98.1% vs SPY) |
| Jul 31, 2026 | Earnings | Earnings: beat the EPS estimate by 4.3% | −5.5% (−6.2% vs SPY) | −7.3% (−10.8% vs SPY) | +86.8% (+83.1% vs SPY) |
| Jul 15, 2026 | Form 144 | Form 144: Stephen Hoge plans to sell $3.6M | +1.2% (+0.8% vs SPY) | −12.3% (−11.8% vs SPY) | −5.8% (−8.5% vs SPY) |
| Jul 8, 2026 | 8-K | Directors and officers: departures, appointments, pay | −7.8% (−7.5% vs SPY) | −16.8% (−17.3% vs SPY) | −34.9% (−37.8% vs SPY) |
| May 1, 2026 | Earnings | Earnings: beat the EPS estimate by 12.4% | −1.2% (−1.5% vs SPY) | +5.5% (+3.7% vs SPY) | +0.3% (−5.1% vs SPY) |
| Mar 5, 2026 | 8-K | Material definitive agreement | −2.5% (−1.1% vs SPY) | −0.8% (+1.4% vs SPY) | −9.9% (−6.8% vs SPY) |
| Feb 13, 2026 | Earnings | Earnings: beat the EPS estimate by 18.9% | +5.1% (+5.1% vs SPY) | +21.8% (+20.6% vs SPY) | +28.5% (+30.3% vs SPY) |
| Nov 24, 2025 | 8-K | Material definitive agreement | +2.5% (+1.5% vs SPY) | −0.4% (−2.3% vs SPY) | +30.5% (+27.0% vs SPY) |
| Nov 6, 2025 | Earnings | Earnings: beat the EPS estimate by 76.6% | +3.2% (+4.3% vs SPY) | +12.5% (+11.7% vs SPY) | +16.2% (+15.0% vs SPY) |
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Moderna: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.